Clinical trial NCT05819957: Therapeutic Education for Multiple System Atrophy (MSA) Patients and Their Caregivers
Official title: Evaluation of a Therapeutic Education Program for Multiple System Atrophy (MSA) Patients : MSA Feasibility
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Multiple System Atrophy
Keywords: TherapeuticEducationProgram
Feasibility
Lead sponsor: University Hospital, Toulouse
Sponsor class: OTHER
First posted: 2023-04-19
Enrollment: 15
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: DIAGNOSTIC

Brief summary: Multiple system atrophy (MSA) is a rare neurodegenerative disorder that leads to major disability, forcing patients and caregivers to adapt their environment and lifestyle. Once they receive the diagnosis, patients and caregivers need to understand the symptoms, cope with them, to digest the diagnosis... All these needs are not completely addressed by the current model of care so we created a therapeutic educational program (TEP) program that will last 12 months, involving both patients and caregivers, including a mixed model of in-person visits and continuous on-line activities. Our project aims to target early MSA patients and their caregivers, proposing to test the feasibility (primary objective) of an innovative therapeutic educational program (TEP) for MSA patients.

Detailed description: The announcement of MSA diagnosis may provoke a shock in patients and their relatives. Educational programs in neurodegenerative diseases, such as Parkinson's disease (PD), offer patients and caregivers structured skills in disease knowledge, expertise, and management. Those programs may result in an improvement of patients' quality of life (QoL), empowering patients and their caregivers to deal with psychosocial challenges. Additionally, it has been shown that educational programs positively impact the perceived health of PD patients without increasing medical costs. There is no educational program for MSA patients. This is the reason why we created the first therapeutic educational program (TEP) for MSA patients and caregivers, including a mix model of in person visits and online classes and virtual activities. Herein, we aim to target early MSA patients (time to diagnosis \< 1 year) and their caregivers, proposing to test the feasibility of this TEP. The program will last 12 months, involving both patients and caregivers, including a mixed model of in-person visits (at baseline and 12 months) and continuous on-line activities (learning situations, questionnaires, quizzes, videos, and interactive exercises).

Eligibility criteria: Inclusion Criteria:

* Patients who have had a clinically probable diagnosis of MSA within the last 3 years or clinically established within the last year
* Presence of a caregiver defined as a spouse, son/daughter or relative who lives with or sees the patient on a regular basis, i.e. at least three times a week.

Exclusion Criteria:

* Patients and/or caregiver unable to give consent
* Patients without access to an internet network or without the material means to access the distance learning modules
* Patients with a life expectancy of less than one year
* Patients with legal guardians, curators, or legal protection
* Patients not affiliated to a social security system
* Patients in a period of exclusion from another study

Primary outcomes:
measure: Feasibility of the program
timeFrame: 1 year
Secondary outcomes:
measure: Recruitment rate
timeFrame: 1 year
measure: Satisfaction rate
timeFrame: 1 year
Other outcomes:
Locations:
city: Toulouse
country: France
facility: CHU Toulouse
Study officials:
affiliation: University Hospital, Toulouse
name: Margherita FABBRI, MD
role: PRINCIPAL_INVESTIGATOR
References: